A Multicenter, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of the Combination Therapy of SCY-078 With Voriconazole in Patients With Invasive Pulmonary Aspergillosis
Phase of Trial: Phase II
Latest Information Update: 21 Feb 2019
At a glance
- Drugs Ibrexafungerp (Primary) ; Voriconazole; Voriconazole
- Indications Aspergillosis
- Focus Adverse reactions
- Acronyms SCYNERGIA
- Sponsors SCYNEXIS
- 11 Feb 2019 Status changed from not yet recruiting to recruiting.
- 06 Nov 2018 Planned initiation date changed from 1 Oct 2018 to 1 Nov 2018.
- 13 Sep 2018 Planned End Date changed from 26 May 2020 to 1 Oct 2020.